Protein detail

LEG8

Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1)

Protein symbol
LEG8
UniProt ID
EVMP score
0.38
Frequency
1
Transmembrane count
Protein classification
Predicted intracellular proteins
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1)
Protein Class
Predicted intracellular proteins
Protein Function
Predicted intracellular proteins
Entrez Gene Symbol
Gene Synonym
PCTA-1
Gene Description
Galectin 8
Chromosome
1
Position
236518000-236552981
Frequency
1
EVMP Score
0.38
Fluorescence & Localization
Tissue SpecificplacentaCell SpecificEarly spermatidsSingle-Nuclei Brain Specificendothelial cell
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

11 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
ligandligandOmniPathYesNoNoNoNo
Page 2 of 2Previous

Regulatory Interaction Network

0 records.

Protein Complex Composition

3 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
LGALS8O002144PDBPDB:3vknPDB:3vklPDB:7p1mPDB:3ojbPDB:3ap6PDB:9fyjPDB:7alsPDB:7p11PDB:3vkmPDB:3apbPDB:3vkoPDB:4bmePDB:3ap4PDB:9fxzPDB:6w4zPDB:7aen
ITGA1LGALS8O00214P561990:0hu.MAP2
CALCOCO2LGALS8O00214Q131372:2PDBPDB:4gxlPDB:4han

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationR Sequencing137324943
Sequence, Structure & Domains

Sequences

Length
317
Mass
35,808
Sequence
MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSDLQSTQASSLELTEISRENVPKSGTPQLRLPFAARLNTPMGPGRTVVVKGEVNANAKSFNVDLLAGKSKDIALHLNPRLNIKAFVRNSFLQESWGEEERNITSFPFSPGMYFEMIIYCDVREFKVAVNGVHSLEYKHRFKELSSIDTLEINGDIHLLEVRSW
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; Synonyms=I; IsoId=O00214-1; Sequence=Displayed; Name=2; IsoId=O00214-2; Sequence=VSP_003094
Alternative Sequence
183; L -> LPSNRGGDISKIAPRTVYTKSKDSTVNHTLTCTKIPPMNYVSK (in isoform 2)

3D Structural Models

Turn
56..59; 221..223; 234..237
Helix
132..134; 157..159; 297..299
Beta Strand
4..6; 9..14; 17..22; 32..38; 44..53; 61..69; 71..73; 75..82; 90..92; 102..109; 111..118; 121..127; 137..143; 145..152; 173..176; 186..193; 200..207; 213..219; 226..233; 238..245; 246..249; 256..258; 266..273; 275..282; 285..291; 302..317
3D Structure
NMR spectroscopy (1); X-ray crystallography (36)

Domain & Motif Annotations

Domain (CC)
Contains two homologous but distinct carbohydrate-binding domains.
Domain (FT)
19..152; Galectin 1; 187..317; Galectin 2
Clinical Relevance
Drug Targets
Clinical trial targetPatented-recorded targetLiterature-reported target
Interaction Protein
ENSG00000106052ENSG00000113595ENSG00000136436
Interaction Count
3
Interaction Dataset
intact_biogrid